# Treatment of Patients With Nephrogenic Systemic Fibrosis With Glivec

> **NCT00981942** · PHASE3 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 10 (actual)

## Conditions studied

- Nephrogenic Systemic Fibrosis

## Interventions

- **DRUG:** Imatinib mesylate (Glivec)

## Key facts

- **NCT ID:** NCT00981942
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00981942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00981942, "Treatment of Patients With Nephrogenic Systemic Fibrosis With Glivec". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00981942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*